Ayurvedic supportive therapy for THALASSEMIA MAJOR

MANAGEMENT OF BEEJADUSHTIJANYA PANDU (THALASSEMIA MAJOR) WITH MUSTA-TRIPHALADI AVALEHA AND GANDHAKADI YOGA

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/10/006306

Enrollment

Registered

2015-10-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- diagnosed patients of Thalassemia Major

Interventions

Intervention1: Group A Trial Group 1 Musta-Triphaladi Avaleha and 2 Gandhakadi Yoga along with modern medical management: DURATION OF THE TREATMENT 12 weeks FOLLOW UP 12 weeks both drugs are a

Eligibility

Inclusion criteria

Inclusion criteria: 1 Diagnosed cases of thalassemia major 2 Age groups 01 year to 10 years of either sex

Exclusion criteria

Exclusion criteria: 1 Children below 01 year and above 10 years of age 2 Cases having HIV HBV infection hepatic failure DM TB etc 3 Patient having BT interval for less than 12 days 4 Patient undergone splenectomy.

Design outcomes

Primary

Measure	Time frame
establish an Adjuvant therapy from Ayurveda in order to 1 prolonging the BT interval 2 decrease the serum ferritin level 3 enhance the life span of the thalassemic children 4 Increase the QOL of thalassemic patients 5 minimise complications such as iron overloading pain etc Timepoint: 1 prolonging the BT interval 2 decrease the serum ferritin level	—

Secondary

Measure	Time frame
1 enhance the life span of the thalassemic children 2 Increase the QOL of thalassemic patients Timepoint: 1 prolonging the BT interval 2 decrease the serum ferritin level	—

Countries

India

Contacts

Public ContactDr Rajagopala S

IPGT and RA

drkspatel2007@yahoo.co.in9427574566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026